VIMRxyn hypericin antiviral: Began Phase I/II trial in 24 HIV-infected patients in Thailand to identify an orally effctive dose with minimal skin phototoxicity.

VIMRx Pharmaceuticals Inc. (VMRX), Stamford, Conn. Product: VIMRxyn hypericin antiviral Indication: HIV infection Status: Began Phase I/II trial in 24 HIV-infected patients in Thailand to identify an ...